CCA
AIFF

Cygnus Capital Advisors’s Firefly Neuroscience AIFF Stock Holding History

Cygnus Capital Advisors’s Portfolio AIFF Stock Details AIFF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$54K Buy
44,552
+24,513
+122% +$42.7K 0.04% 60
2026
Q1 		$44K Buy
+20,039
New +$24.9K 0.03% 76

Other funds holding AIFF

M
Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Cygnus Capital Advisors's AIFF Position: Q2 2026 in Review

Cygnus Capital Advisors increased its Firefly Neuroscience (AIFF) stake by 122% in Q2 2026, buying an estimated $42.7K and bringing the position to 44,552 shares worth $54K. The position accounts for 0.04% of the portfolio, ranked #60.

Cygnus Capital Advisors first reported a position in AIFF in Q1 2026 and has held it in 2 quarters since. 23 funds tracked by Wall St. Rank hold AIFF as of Q2 2026.

  • Cygnus Capital Advisors held 44,552 shares of Firefly Neuroscience worth $54K as of Q2 2026.
  • Cygnus Capital Advisors bought 24,513 Firefly Neuroscience shares in Q2 2026, an estimated $42.7K.
  • Firefly Neuroscience made up 0.04% of Cygnus Capital Advisors's portfolio in Q2 2026, its #60 holding.
  • Cygnus Capital Advisors first reported a position in Firefly Neuroscience in Q1 2026 and has held it in 2 quarters since.
  • 23 funds tracked by Wall St. Rank held Firefly Neuroscience as of Q2 2026.

Based on Cygnus Capital Advisors's 13F filing for Q2 2026, filed 3 Sep 2026.